Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

T058: Safety and Dose-Expansion Study of Combination Favezelimab (Anti–lag-3) Plus Pembrolizumab in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Refractory to Anti–PD-1 Treatment

John Timmerman,David Lavie,Nathalie A. Johnson,Abraham Avigdor,Peter Borchmann,Charalambos Andreadis,Ali Bazargan,Gareth Gregory,Colm Keane,Inna Tzoran,Vladan Vucinic,Pier Luigi Zinzani,Hong Zhang,Pallavi Pillai,Akash Nahar,Alex F. Herrera

HemaSphere（2022）

Cited 0|Views11

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined